General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

Press releases

2014
  • 12-November-2014
    Novartis and Malaria No More help fulfill malaria treatment goal in Zambia by raising funds for three million treatments through Power of One

    Read this press release

  • 31-July-2014
    KAE609 shows promise as next generation treatment for malaria

    Read this press release

  • 25-June-2014
    Novartis convenes 13th annual malaria expert panel with a focus on access to quality antimalarials across Africa

    Read this press release

  • 7-April-2014
    Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia

    Read this press release

2013
  • 28-November-2013
    New malaria target identified with potential to prevent, block, and treat multiple stages of the malaria life cycle

    Read this press release

  • 14-November-2013
    Novartis honored by Malaria No More corporate citizenship award in recognition of long-standing commitment to eliminating disease

    Read this press release

  • 23-September-2013
    Malaria No More and Novartis launch Power of One, a global digital fundraising campaign to help eliminate malaria deaths

    Read this press release

  • 26-June-2013
    Novartis convenes international malaria experts to expand access to quality-assured antimalarial treatment in Africa

    Read this press release

  • 25-April-2013
    Novartis signs on to support Malaria No More's Power of One campaign to stride towards a future without malaria

    Read this press release

2012
  • 12-June-2012
    Malaria experts join forces with Novartis to empower local communities to tackle malaria in Africa

    Read this press release

2011
  • 17-Nov-2011
    Novartis and collaborators discover new dual-acting class of antimalarial compounds with potential to both prevent and treat malaria infections

    Read this press release

  • 13-Jul-2011
    Novartis Malaria Initiative hosts the 10th NMCP Best Practice Sharing Workshop in Benin

    Read this press release

  • 18-May-2011
    IMD case study reveals business learnings from SMS for Life project

    Read this press release

  • 18-Apr-2011
    Improving access to essential malaria treatments on World Malaria Day

    Read this press release

2010
2009
  • 06-Jul-2009
    Novartis delivers 250,000,000th Coartem® treatment and becomes first healthcare company to join United Against Malaria partnership

    Read this press release

  • 13-May-2009
    Scientists who developed Novartis Coartem® and Glivec® receive 2009

    Download this press release

  • 8-Apr-2009
    Coartem® receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US

    Download this press release

  • 27-Jan-2009
    Novartis and Medicines for Malaria Venture launch Coartem® Dispersible, the first ACT developed for children suffering from malaria

    Download this press release

2008

23-Apr-2008
Novartis announces 20% average reduction in price of malaria drug Coartem® to further accelerate access in malaria-endemic regions

Download this press release